How to Buy Petmed Express Stock
Petmed Express Inc
PetMed Express, Inc. , together with its subsidiaries, operates as a pet pharmacy in the United States.
Petmed Express stock last closed at $3.24, up 3.85% from the previous day, and has decreased 14.96% in one year. It has overperformed other stocks in the Pharmaceutical Retailers industry by 0.17 percentage points. Petmed Express stock is currently +11.72% from its 52-week low of $2.90, and -52.7% from its 52-week high of $6.85.
At the moment, there are 20.66M shares of PETS outstanding. The market capitalization of PETS is $66.93M. In the last 24 hours, 273,000 PETS shares were traded.
How to Buy Petmed Express Stock
Not sure how to invest in Petmed Express stock? Here's how.
- Figure out where to buy Petmed Express stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Petmed Express stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Pick your payment method and add your information.
- Analyze Petmed Express stock: The Petmed Express ticker symbol is PETS. Is Petmed Express stock a good investment? Should you buy shares of PETS? How do PETS's underlying business fundamentals look? Do top analysts think Petmed Express is a good buy? Why has PETS's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PETS is a good stock to buy).
- Execute your PETS trade: Decide if you will purchase PETS shares at the current market price or use a limit order to buy PETS shares at a particular price.
- Keep tabs on your PETS investment: Create a watchlist to keep tabs on your position in Petmed Express shares.
Step 1: Figure out where to buy Petmed Express stock
You need a brokerage account in order to access the NASDAQ market and buy PETS shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal details so you can invest in PETS today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create your new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best stock app, your next step is to transfer the money for your investment:
Check out the video below to see the process of depositing money into your investment account.
Step 4: Analyze Petmed Express stock
Once you have selected the best place to buy Petmed Express stock, it's important to research their stock before you buy, so you can wrap your head around the risk as well as the opportunity.
Petmed Express stock at a glance
PETS Overview
WallStreetZen was created to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on PETS's stock page.
Is PETS stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PETS's true value.
Using relative valuations ratios:
- PETS could be overvalued based on its P/E ratio of 324x, relative to Pharmaceutical Retailers industry P/E ratio of 0.21x
- PETS could be undervalued based on its P/B ratio of 0.7x, relative to Pharmaceutical Retailers industry P/B ratio of 1.4x
You can do more valuation analysis on PETS's stock here.
Is PETS a healthy company?
Pros:
- PETS profit margin has gone up from -1% to 0.1% in the past year.
- PETS earnings of $1.40M is not enough to cover its interest payments.
- PETS's operating cash flow of $4.83M allows it to safely service it's debt of $1.11M.
- There are more short-term assets than short-term liabilities on the PETS balance sheet.
- There are more short-term assets than long-term liabilities on the PETS balance sheet.
Cons:
- PETS has a relatively high debt to equity ratio of 0.51.
- Total PETS debt is higher than 5 years ago, relative to shareholder equity.
Is Petmed Express stock a Buy, Hold, or Sell, according to analysts?
Out of 1 sell side analysts who give ratings on PETS, the consensus analyst rating on Petmed Express is a Strong Sell
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Petmed Express stock forecast page.
PETS Technical Indicators
PETS Performance Numbers
Last year, PETS earnings were $357.00k. During the past five year, PETS's earnings have grown by -61.93% per year. This was slower than the Pharmaceutical Retailers industry average of -0.39%.
Last year, PETS revenue was $247.01M. In the last 5 year, PETS's revenue has increased by -2.08% per year. This was slower than the Pharmaceutical Retailers industry average of 6.9%.
You can research PETS's earnings and revenue performance here.
Latest Insiders Trades at PETS
In the last 12 months, executives and large shareholders at PETS have bought more shares than they have sold.
Nina Capital Holdings Inc, 10% Owner of PETS, was the latest PETS insider to buy. They bought $87,425.00 worth of PETS stock on Jul 21, 2025.
Research more about who owns PETS shares here.
Can I get consistent income from PETS stock?
No, Petmed Express doesn't provide an income stream by paying out dividends.
What do other investors have to say about PETS?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your PETS trade
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular price limit, use a limit order.
Hit the Open Trade button and eToro will place your order.
If you want additional help buying stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your PETS investment
Now that you own some PETS shares, you'll want to stay up-to-date on your new investment.
Make a watchlist to get notified of important updates regarding your PETS stock.
PETS Feed
How to Buy Stock in Petmed Express
To reiterate, here are the 6 steps for buying Petmed Express stock:
- Figure out where to buy Petmed Express stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Analyze Petmed Express stock
- Execute your PETS trade
- Keep tabs on your PETS investment
If you require a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep track of your new investment in Petmed Express, create your watchlist below.
Other Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.